Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center.

Diabetes & metabolic syndrome

Sandra S, Lesmana CRA, Purnamasari D, Kurniawan J, Gani RA.
PMID: 30641737
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):424-428. doi: 10.1016/j.dsx.2018.10.001. Epub 2018 Oct 10.

BACKGROUND AND AIM: Hyperuricemia is one of the metabolic parameter which has been considered to play an important role in non-alcoholic fatty liver disease (NAFLD). However, there is still lack of studies about association between serum uric acid with...

Cite
Sandra S, Lesmana CRA, Purnamasari D, et al. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center. Diabetes Metab Syndr. 2018;13(1):424-428doi: 10.1016/j.dsx.2018.10.001.
Sandra, S., Lesmana, C. R. A., Purnamasari, D., Kurniawan, J., & Gani, R. A. (2019). Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center. Diabetes & metabolic syndrome, 13(1), 424-428. https://doi.org/10.1016/j.dsx.2018.10.001
Sandra, Sharon, et al. "Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center." Diabetes & metabolic syndrome vol. 13,1 (2019): 424-428. doi: https://doi.org/10.1016/j.dsx.2018.10.001
Sandra S, Lesmana CRA, Purnamasari D, Kurniawan J, Gani RA. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center. Diabetes Metab Syndr. 2019 Jan - Feb;13(1):424-428. doi: 10.1016/j.dsx.2018.10.001. Epub 2018 Oct 10. PMID: 30641737.
Copy Download .nbib Format: NLM
Regional difference in the susceptibility of non-alcoholic fatty liver disease in China.

BMJ open diabetes research & care

Xia M, Sun X, Zheng L, Bi Y, Li Q, Sun L, Di F, Li H, Zhu D, Gao Y, Bao Y, Wang Y, He L, Wu B, Wang S, Gao J, Gao X, Bian H.
PMID: 32522731
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001311.

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a global health problem with high geographic heterogeneity. We aimed to investigate regional-specific concomitant rate of NAFLD and quantitative relationship between liver fat content (LFC) and glucose metabolism parameters in representative clinical...

Cite
Xia M, Sun X, Zheng L, et al. Regional difference in the susceptibility of non-alcoholic fatty liver disease in China. BMJ Open Diabetes Res Care. 2020;8(1)doi: 10.1136/bmjdrc-2020-001311.
Xia, M., Sun, X., Zheng, L., Bi, Y., Li, Q., Sun, L., Di, F., Li, H., Zhu, D., Gao, Y., Bao, Y., Wang, Y., He, L., Wu, B., Wang, S., Gao, J., Gao, X., & Bian, H. (2020). Regional difference in the susceptibility of non-alcoholic fatty liver disease in China. BMJ open diabetes research & care, 8(1), . https://doi.org/10.1136/bmjdrc-2020-001311
Xia, Mingfeng, et al. "Regional difference in the susceptibility of non-alcoholic fatty liver disease in China." BMJ open diabetes research & care vol. 8,1 (2020). doi: https://doi.org/10.1136/bmjdrc-2020-001311
Xia M, Sun X, Zheng L, Bi Y, Li Q, Sun L, Di F, Li H, Zhu D, Gao Y, Bao Y, Wang Y, He L, Wu B, Wang S, Gao J, Gao X, Bian H. Regional difference in the susceptibility of non-alcoholic fatty liver disease in China. BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001311. PMID: 32522731; PMCID: PMC7287499.
Copy Download .nbib Format: NLM
Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study.

JNMA; journal of the Nepal Medical Association

Bc B, Jaiswal RK, Gupta PK, Paudel R, Subedi RK.
PMID: 34508436
JNMA J Nepal Med Assoc. 2021 May 25;59(237):454-459. doi: 10.31729/jnma.5719.

INTRODUCTION: Non-alcoholic fatty liver disease is fatty infiltration of the liver in the absence of other causes of steatosis. It is strongly associated with central adiposity, high body mass index, insulin resistance states, hypertension, hyperlipidemia which are features of...

Cite
Bc B, Jaiswal RK, Gupta PK, et al. Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2021;59(237):454-459doi: 10.31729/jnma.5719.
Bc, B., Jaiswal, R. K., Gupta, P. K., Paudel, R., & Subedi, R. K. (2021). Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA; journal of the Nepal Medical Association, 59(237), 454-459. https://doi.org/10.31729/jnma.5719
Bc, Bom, et al. "Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study." JNMA; journal of the Nepal Medical Association vol. 59,237 (2021): 454-459. doi: https://doi.org/10.31729/jnma.5719
Bc B, Jaiswal RK, Gupta PK, Paudel R, Subedi RK. Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2021 May 25;59(237):454-459. doi: 10.31729/jnma.5719. PMID: 34508436; PMCID: PMC8673453.
Copy Download .nbib Format: NLM
To screen or not to screen for NAFLD?.

Medical ultrasonography

Sporea I.
PMID: 34015069
Med Ultrason. 2021 May 20;23(2):133-134. doi: 10.11152/mu-3251.

.

Cite
Sporea I. To screen or not to screen for NAFLD?. Med Ultrason. 2021;23(2):133-134doi: 10.11152/mu-3251.
Sporea, I. (2021). To screen or not to screen for NAFLD?. Medical ultrasonography, 23(2), 133-134. https://doi.org/10.11152/mu-3251
Sporea, Ioan. "To screen or not to screen for NAFLD?." Medical ultrasonography vol. 23,2 (2021): 133-134. doi: https://doi.org/10.11152/mu-3251
Sporea I. To screen or not to screen for NAFLD?. Med Ultrason. 2021 May 20;23(2):133-134. doi: 10.11152/mu-3251. PMID: 34015069.
Copy Download .nbib Format: NLM
Editorial for "Automated Analysis of Multiparametric MRI/MRE Exams for Prediction of NASH".

Journal of magnetic resonance imaging : JMRI

Torkzad MR.
PMID: 33565156
J Magn Reson Imaging. 2021 Jul;54(1):132-133. doi: 10.1002/jmri.27540. Epub 2021 Feb 09.

No abstract available.

Cite
Torkzad MR. Editorial for "Automated Analysis of Multiparametric MRI/MRE Exams for Prediction of NASH". J Magn Reson Imaging. 2021;54(1):132-133doi: 10.1002/jmri.27540.
Torkzad, M. R. (2021). Editorial for "Automated Analysis of Multiparametric MRI/MRE Exams for Prediction of NASH". Journal of magnetic resonance imaging : JMRI, 54(1), 132-133. https://doi.org/10.1002/jmri.27540
Torkzad, Michael R. "Editorial for "Automated Analysis of Multiparametric MRI/MRE Exams for Prediction of NASH"." Journal of magnetic resonance imaging : JMRI vol. 54,1 (2021): 132-133. doi: https://doi.org/10.1002/jmri.27540
Torkzad MR. Editorial for "Automated Analysis of Multiparametric MRI/MRE Exams for Prediction of NASH". J Magn Reson Imaging. 2021 Jul;54(1):132-133. doi: 10.1002/jmri.27540. Epub 2021 Feb 09. PMID: 33565156.
Copy Download .nbib Format: NLM
Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done.

Hepatology (Baltimore, Md.)

Hannah WN, Harrison SA.
PMID: 26891023
Hepatology. 2016 Jun;63(6):1762-4. doi: 10.1002/hep.28504. Epub 2016 Mar 29.

No abstract available.

Cite
Hannah WN, Harrison SA. Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done. Hepatology. 2016;63(6):1762-4doi: 10.1002/hep.28504.
Hannah, W. N., & Harrison, S. A. (2016). Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done. Hepatology (Baltimore, Md.), 63(6), 1762-4. https://doi.org/10.1002/hep.28504
Hannah, William N, and Harrison, Stephen A. "Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done." Hepatology (Baltimore, Md.) vol. 63,6 (2016): 1762-4. doi: https://doi.org/10.1002/hep.28504
Hannah WN, Harrison SA. Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done. Hepatology. 2016 Jun;63(6):1762-4. doi: 10.1002/hep.28504. Epub 2016 Mar 29. PMID: 26891023.
Copy Download .nbib Format: NLM
Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study.

JNMA; journal of the Nepal Medical Association

Bc B, Jaiswal RK, Gupta PK, Paudel R, Subedi RK.
PMID: 34508436
JNMA J Nepal Med Assoc. 2021 May 25;59(237):454-459. doi: 10.31729/jnma.5719.

INTRODUCTION: Non-alcoholic fatty liver disease is fatty infiltration of the liver in the absence of other causes of steatosis. It is strongly associated with central adiposity, high body mass index, insulin resistance states, hypertension, hyperlipidemia which are features of...

Cite
Bc B, Jaiswal RK, Gupta PK, et al. Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2021;59(237):454-459doi: 10.31729/jnma.5719.
Bc, B., Jaiswal, R. K., Gupta, P. K., Paudel, R., & Subedi, R. K. (2021). Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA; journal of the Nepal Medical Association, 59(237), 454-459. https://doi.org/10.31729/jnma.5719
Bc, Bom, et al. "Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study." JNMA; journal of the Nepal Medical Association vol. 59,237 (2021): 454-459. doi: https://doi.org/10.31729/jnma.5719
Bc B, Jaiswal RK, Gupta PK, Paudel R, Subedi RK. Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2021 May 25;59(237):454-459. doi: 10.31729/jnma.5719. PMID: 34508436.
Copy Download .nbib Format: NLM
Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity.

Journal of pediatric gastroenterology and nutrition

Orkin S, Brokamp C, Yodoshi T, Trout AT, Liu C, Meryum S, Taylor S, Wolfe C, Sheridan R, Seth A, Bhuiyan MAN, Ley S, Arce-Clachar AC, Bramlage K, Kahn R, Xanthakos S, Beck AF, Mouzaki M.
PMID: 31651666
J Pediatr Gastroenterol Nutr. 2020 Mar;70(3):364-370. doi: 10.1097/MPG.0000000000002527.

BACKGROUND AND OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is linked to obesity. Obesity is associated with lower socioeconomic status (SES). An independent link between pediatric NAFLD and SES has not been elucidated. The objective of this study was to...

Cite
Orkin S, Brokamp C, Yodoshi T, et al. Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. J Pediatr Gastroenterol Nutr. 2020;70(3):364-370doi: 10.1097/MPG.0000000000002527.
Orkin, S., Brokamp, C., Yodoshi, T., Trout, A. T., Liu, C., Meryum, S., Taylor, S., Wolfe, C., Sheridan, R., Seth, A., Bhuiyan, M. A. N., Ley, S., Arce-Clachar, A. C., Bramlage, K., Kahn, R., Xanthakos, S., Beck, A. F., & Mouzaki, M. (2020). Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. Journal of pediatric gastroenterology and nutrition, 70(3), 364-370. https://doi.org/10.1097/MPG.0000000000002527
Orkin, Sarah, et al. "Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity." Journal of pediatric gastroenterology and nutrition vol. 70,3 (2020): 364-370. doi: https://doi.org/10.1097/MPG.0000000000002527
Orkin S, Brokamp C, Yodoshi T, Trout AT, Liu C, Meryum S, Taylor S, Wolfe C, Sheridan R, Seth A, Bhuiyan MAN, Ley S, Arce-Clachar AC, Bramlage K, Kahn R, Xanthakos S, Beck AF, Mouzaki M. Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. J Pediatr Gastroenterol Nutr. 2020 Mar;70(3):364-370. doi: 10.1097/MPG.0000000000002527. PMID: 31651666; PMCID: PMC8054652.
Copy Download .nbib Format: NLM
Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?.

Diabetes & metabolism

Caussy C.
PMID: 32750452
Diabetes Metab. 2020 Sep;46(4):259-260. doi: 10.1016/j.diabet.2020.07.009. Epub 2020 Aug 01.

No abstract available.

Cite
Caussy C. Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?. Diabetes Metab. 2020;46(4):259-260doi: 10.1016/j.diabet.2020.07.009.
Caussy, C. (2020). Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?. Diabetes & metabolism, 46(4), 259-260. https://doi.org/10.1016/j.diabet.2020.07.009
Caussy, Cyrielle. "Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?." Diabetes & metabolism vol. 46,4 (2020): 259-260. doi: https://doi.org/10.1016/j.diabet.2020.07.009
Caussy C. Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?. Diabetes Metab. 2020 Sep;46(4):259-260. doi: 10.1016/j.diabet.2020.07.009. Epub 2020 Aug 01. PMID: 32750452.
Copy Download .nbib Format: NLM
Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease.

Diabetes & metabolism journal

Choi SJ, Kim SM, Kim YS, Kwon OS, Shin SK, Kim KK, Lee K, Park IB, Choi CS, Chung DH, Jung J, Paek M, Lee DH.
PMID: 33108854
Diabetes Metab J. 2021 Sep;45(5):739-752. doi: 10.4093/dmj.2020.0137. Epub 2020 Oct 28.

BACKGROUND: Several noninvasive tools are available for the assessment of nonalcoholic fatty liver disease (NAFLD) including clinical and blood biomarkers, transient elastography (TE), and magnetic resonance imaging (MRI) techniques, such as proton density fat fraction (MRI-PDFF) and magnetic resonance...

Cite
Choi SJ, Kim SM, Kim YS, et al. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease. Diabetes Metab J. 2020;45(5):739-752doi: 10.4093/dmj.2020.0137.
Choi, S. J., Kim, S. M., Kim, Y. S., Kwon, O. S., Shin, S. K., Kim, K. K., Lee, K., Park, I. B., Choi, C. S., Chung, D. H., Jung, J., Paek, M., & Lee, D. H. (2021). Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease. Diabetes & metabolism journal, 45(5), 739-752. https://doi.org/10.4093/dmj.2020.0137
Choi, Seung Joon, et al. "Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease." Diabetes & metabolism journal vol. 45,5 (2021): 739-752. doi: https://doi.org/10.4093/dmj.2020.0137
Choi SJ, Kim SM, Kim YS, Kwon OS, Shin SK, Kim KK, Lee K, Park IB, Choi CS, Chung DH, Jung J, Paek M, Lee DH. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease. Diabetes Metab J. 2021 Sep;45(5):739-752. doi: 10.4093/dmj.2020.0137. Epub 2020 Oct 28. PMID: 33108854; PMCID: PMC8497935.
Copy Download .nbib Format: NLM
Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease.

Magnetic resonance imaging

Ahn JH, Yu JS, Park KS, Kang SH, Huh JH, Chang JS, Lee JH, Kim MY, Nickel MD, Kannengiesser S, Kim JY, Koh SB.
PMID: 33798658
Magn Reson Imaging. 2021 Jul;80:1-8. doi: 10.1016/j.mri.2021.03.015. Epub 2021 Mar 30.

PURPOSE: This study investigated whether T1 values in native T1 mapping of 3T magnetic resonance imaging (MRI) of the liver were affected by the fatty component.METHODS: This prospective study involved 340 participants from a population-based cohort study between May...

Cite
Ahn JH, Yu JS, Park KS, et al. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease. Magn Reson Imaging. 2021;80:1-8doi: 10.1016/j.mri.2021.03.015.
Ahn, J. H., Yu, J. S., Park, K. S., Kang, S. H., Huh, J. H., Chang, J. S., Lee, J. H., Kim, M. Y., Nickel, M. D., Kannengiesser, S., Kim, J. Y., & Koh, S. B. (2021). Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease. Magnetic resonance imaging, 801-8. https://doi.org/10.1016/j.mri.2021.03.015
Ahn, Jhii-Hyun, et al. "Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease." Magnetic resonance imaging vol. 80 (2021): 1-8. doi: https://doi.org/10.1016/j.mri.2021.03.015
Ahn JH, Yu JS, Park KS, Kang SH, Huh JH, Chang JS, Lee JH, Kim MY, Nickel MD, Kannengiesser S, Kim JY, Koh SB. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease. Magn Reson Imaging. 2021 Jul;80:1-8. doi: 10.1016/j.mri.2021.03.015. Epub 2021 Mar 30. PMID: 33798658.
Copy Download .nbib Format: NLM
Non-invasive assessment of non-alcoholic fatty liver disease: ultrasound and transient elastography.

Reviews on recent clinical trials

Berzigotti A.
PMID: 25514917
Rev Recent Clin Trials. 2014;9(3):170-7. doi: 10.2174/1574887109666141216101630.

Non-alcoholic fatty liver disease (NAFLD) is extremely prevalent in the Western world. Non-invasive diagnostic methods should be able to reflect the presence and severity of liver fatty changes and the presence and severity of hepatic inflammation and fibrosis (features...

Cite
Berzigotti A. Non-invasive assessment of non-alcoholic fatty liver disease: ultrasound and transient elastography. Rev Recent Clin Trials. 2014;9(3):170-7doi: 10.2174/1574887109666141216101630.
Berzigotti, A. (2014). Non-invasive assessment of non-alcoholic fatty liver disease: ultrasound and transient elastography. Reviews on recent clinical trials, 9(3), 170-7. https://doi.org/10.2174/1574887109666141216101630
Berzigotti, Annalisa. "Non-invasive assessment of non-alcoholic fatty liver disease: ultrasound and transient elastography." Reviews on recent clinical trials vol. 9,3 (2014): 170-7. doi: https://doi.org/10.2174/1574887109666141216101630
Berzigotti A. Non-invasive assessment of non-alcoholic fatty liver disease: ultrasound and transient elastography. Rev Recent Clin Trials. 2014;9(3):170-7. doi: 10.2174/1574887109666141216101630. PMID: 25514917.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries